ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,504 | -19.7% | 5,042 | -9.1% | 0.06% | -17.9% |
| Q2 2023 | $112,680 | +105.2% | 5,548 | +84.3% | 0.07% | +123.3% |
| Q1 2023 | $54,902 | -36.3% | 3,010 | -27.7% | 0.03% | -33.3% |
| Q4 2022 | $86,153 | -35.2% | 4,166 | -17.8% | 0.04% | -15.1% |
| Q3 2022 | $133,000 | +4.7% | 5,068 | +0.8% | 0.05% | +12.8% |
| Q2 2022 | $127,000 | +1.6% | 5,029 | +27.2% | 0.05% | -16.1% |
| Q1 2022 | $125,000 | -26.0% | 3,954 | -5.4% | 0.06% | -12.5% |
| Q4 2021 | $169,000 | -44.0% | 4,179 | -51.8% | 0.06% | -51.9% |
| Q3 2021 | $302,000 | +20.8% | 8,664 | -4.9% | 0.13% | +29.1% |
| Q2 2021 | $250,000 | -4.6% | 9,111 | -2.5% | 0.10% | -7.2% |
| Q1 2021 | $262,000 | +9.6% | 9,348 | +1.7% | 0.11% | +12.1% |
| Q4 2020 | $239,000 | +25.8% | 9,188 | -17.0% | 0.10% | -1.0% |
| Q3 2020 | $190,000 | -39.1% | 11,075 | -12.1% | 0.10% | -32.4% |
| Q2 2020 | $312,000 | -22.0% | 12,599 | -56.1% | 0.15% | +261.0% |
| Q3 2018 | $400,000 | -34.3% | 28,669 | -42.4% | 0.04% | -92.4% |
| Q2 2018 | $609,000 | – | 49,734 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $65,241,000 | 19.83% |
| Octagon Capital Advisors LP | 2,095,231 | $84,794,000 | 16.50% |
| EcoR1 Capital, LLC | 5,523,358 | $223,530,000 | 7.12% |
| BVF INC/IL | 3,398,067 | $137,520,000 | 4.99% |
| PFM Health Sciences, LP | 3,431,010 | $138,853,000 | 4.73% |
| Alphabet Inc. | 2,563,441 | $103,742,000 | 2.50% |
| Boxer Capital, LLC | 1,432,200 | $57,961,000 | 2.25% |
| PARK CIRCLE Co | 64,000 | $2,590,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 283,210 | $11,462,000 | 1.72% |
| DAFNA Capital Management LLC | 117,200 | $4,743,000 | 1.19% |